Approval · Notice of Compliance 9149 · 2007
PRAVASA: Notice of Compliance 9149
Issued November 1, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9149
- Date
- November 1, 2007
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New 325 mg strength of acetylsalicylic acid co-package with pravastatin sodium sodium (10mg, 20mg and 40mg) and other revisions to the product monograph
- Therapeutic class
- Platelet aggregation inhibitor and lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRAVASA | 02301601 | — |
| PRAVASA | 02301628 | — |
| PRAVASA | 02301636 | — |
Medicinal ingredients
- ACETYLSALICYLIC ACID 325 MG per TAB
- PRAVASTATIN SODIUM 10 MG per TAB
- PRAVASTATIN SODIUM 20 MG per TAB
- PRAVASTATIN SODIUM 40 MG per TAB